Background The objective of this study was to review methodological quality of economic evaluations of lifestyle behavior change interventions (LBCIs) and to examine how they address methodological challenges for public health economic evaluation identified in the literature.
Introduction
Lifestyle behavior is responsible for a large part of the disease burden to society. Therefore, interventions to change lifestyle behaviors, such as smoking, physical activity, diet and alcohol use, are increasingly developed. 1 As public resources are limited, policy-makers should give priority to lifestyle behavior change interventions (LBCIs) that produce the largest benefit per dollar invested. Economic evaluation studies can assist in this process by providing insights into the relative costs and benefits of interventions.
2 Such studies become increasingly available for LBCIs, 3, 4 but their methodological quality has been questioned 5 and there is increasing recognition that methods, which have been developed to evaluate bio-medical health interventions, need amendments to deal with the challenges posed by public health interventions, such as LBCIs. 6 -8 Six key challenges have been identified in the literature. Four of these concern the measurement of intervention outcomes: (i) as health benefits of LBCIs take a long time to accrue, lengthy follow-up periods are needed or intermediate outcomes need to be translated to final outcomes (e.g. survival); (ii) LBCIs may produce a broad number of outcomes, which are not fully captured by standard measures of health outcome, such as quality-adjusted life-years (QALYs); 8, 9 (iii) LBCIs may have consequences for people, who are not directly targeted by the intervention or the community at large. 7, 10 Outcome measurement in economic evaluation, however, tends to focus on individual intervention participants only; (iv) many LBCIs are designed to achieve more health equity, but methods to account for equity outcomes in economic evaluation are not well developed. 11, 12 The identification and measurement of costs create a fifth challenge. LBCIs take place in a wide range of settings and often produce costs outside the health sector. How to deal with non-health sector costs in economic evaluations is still unclear.
7, 13 Finally, there is discussion about the study design for evaluating effectiveness. Most economic evaluation guidelines indicate a preference for randomized controlled trials (RCTs), which are not always feasible in the context of LBCIs.
7, 12 -14 The aim of this research was 2-fold: (i) to examine the general methodological quality of economic evaluations of LBCIs and (ii) to examine how they addressed the six challenges for public health economic evaluation.
Methods
A systematic literature review was conducted focusing on six key areas for behavior change: smoking, physical activity, dietary behavior, (illegal) drug use, alcohol use and sexual behavior. Relevant references (n ¼ 5798) were identified through PubMed and the NHS economic evaluation database (see Supplementary data, Appendix 1 for the search strategy). From these we selected 142 for inclusion in this study (see Fig. 1 for the selection strategy and Supplementary data, Appendix 2 for full references).
Data extraction and analysis
Included studies were divided between six reviewers (A.G., S.E., D.A., A.A., J.T. and J.S.). One reviewer assessed each study using a data extraction form, piloted by the research team, on 20 randomly selected articles. Data were extracted on general study characteristics, characteristics of the LBCIs evaluated, methodological quality and handling of methodological challenges. Methodological quality was examined using the 10 main questions of a checklist for assessing economic evaluations developed by Drummond et al.
2 (see Table 2 ). Due to ongoing discussion about the types of costs and consequences to be considered in public health economic evaluations, we further specified question 4 and focused only on program costs, survival and health-related quality of life outcomes. Question 10 was discarded, because examples and instructions regarding this question did not provide specific criteria for assessment.
To assess handling of the six methodological challenges, we extracted data about study design and time horizon. Outcome measures used were identified and classified into the following categories: (i) intermediate outcomes, such as behavior changes (e.g. smoking cessation) or biomedical health indicators (e.g. body mass index); (ii) health outcomes, measured in terms of morbidity or disease occurrence Excluded references (n = 91)
• Study is no full economic evaluation (n = 3747)
• Evaluated intervention(s) do not aim to change behavior in the six selected areas (n = 758)
• All evaluated intervention(s) include medical, surgical, pharmacological or therapeutic treatment procedures (n = 594)
• Study is not published in English or concerns animal research (n = 349)
• Study is no full economic evaluation (n = 62)
• Study is a double publication (n = 2)
• Evaluated intervention(s) do not aim to change behavior in the six selected areas (n = 27) 
Results
General study characteristics of the economic evaluation studies and LBCIs evaluated are displayed in Table 1 . Table 2 displays several methodological shortcomings. Only two-thirds of the economic evaluations reported a welldefined research question. The perspective of the analysis was for example only explicitly stated by 57% of the studies (n ¼ 81). Less than half of the studies described the alternatives under evaluation in sufficient detail and specific behavior change techniques could only be determined for 11 studies (7.7%). Relevant costs and consequences were identified by only 41% (n ¼ 58) of the studies, despite the fact that we restricted ourselves to considering program costs, survival and HRQOL outcomes. Measurement and valuation of costs and consequences were rated as accurate in more than two-thirds of the studies. From studies with a time horizon exceeding 1 year (n ¼ 89) only 78.7% (n ¼ 70) used discounting to adjust for differential timing of costs and consequences. Incremental analysis was conducted by less than two-thirds of the studies (59.8%). Studies performing sensitivity analyses (n ¼ 98, 69%) to account for uncertainty in estimated parameters usually did this consistently for both costs and consequences (n ¼ 73, 74.5%). But in less than half of the cases (n ¼ 43, 43.9%) authors gave justifications for the value ranges or distributions used. Likewise, relatively few studies performed sensitivity analyses on the discount rate (n ¼ 41, 41.8%). Economic evaluations scored better regarding program effectiveness, which was either established beforehand or examined simultaneously with the economic evaluation by 93% of the studies (n ¼ 132). Methodological quality of more recently published studies (2001 -09) was comparable with the total sample. 
Methodological quality

Continued
Handling of challenges
Design and time horizon of economic evaluations Model-based studies (n ¼ 56) were equally represented as trial-based (n ¼ 58) studies and 23 studies (16.2%) used a combination of both approaches (see Table 1 ). Five studies did not describe study design. Trial-based studies generally had a follow-up of 2 years or less (n ¼ 48). Only six studies had longer follow-up periods (up to 5 years). This is long for a trial, but insufficient to assess long-term health consequences of LBCIs. Modeling is a useful approach to extrapolate study findings beyond the trial period. From the 79 studies with a modeling component, only 38% (n ¼ 30) calculated lifetime intervention consequences, as recommended by good practice guidelines. 15 Scope of outcomes considered Outcomes incorporated in the studies are summarized in 18 improved daily stress management, increased problem-solving ability and self-efficacy, 19 unwanted pregnancies prevented, 20,21 increased endurance levels, 22 intervention recall, 23 reduced sick leave, 24, 25 hospital admissions 26 and outpatient visits). 26, 27 None of the studies examined the impact of LBCIs on equity outcomes or explored whether cost-effectiveness varied for different socio-economic groups.
Twelve studies (8.5%) incorporated outcomes for not directly targeted individuals. Most of these (n ¼ 10) evaluated interventions addressing sexual behaviors. 21,28 -36 They incorporated either health outcomes (i.e. HIV and other STD infections averted) or final outcomes (i.e. life years and QALYs gained) among sexual partners of targeted individuals. Two studies evaluated interventions in other behavior change areas. One evaluated a nutrition education intervention and accounted for education spillovers and external benefits to people in the environment of targeted individuals. 37 The other study evaluated a prenatal health education program and described how the program affected children's birth weight of participating mothers. 38 Community level outcomes were only incorporated by one study evaluating an intervention for problem drinkers. 39 The authors ascribed a monetary value to reduced quality of life caused by crimes and accidents based on jury compensations paid for pain and suffering caused by physical injuries and fear.
Nineteen studies (13.4%) identified potentially relevant outcomes of LBCIs not incorporated in the economic evaluation due to a lack of adequate methods or limited scope of the research. These mostly concerned outcomes for individuals not directly targeted (i.e. health outcomes, survival, behavior changes and other intermediate outcomes, such as empowerment of staff delivering the intervention) and outcomes for intervention participants not captured by standard measures of health outcome (e.g. changes in quality of life due to withdrawal symptoms or psychological wellbeing resulting from physical activity). Few studies (n ¼ 5) identified community level outcomes, such as a better sense of community, increased community support and the emergence of a black market due to changes in smoking legislation. Table 1 shows that the majority of studies included direct program costs (n ¼ 133, 93.7%), health-care costs (n ¼ 90, 63.4%) or both (n ¼ 84, 59.2%). Eleven studies (7.7%) included costs in other societal sectors, 20,39 -48 such as costs of motor-vehicle accidents, violent crimes, incarceration, personal injury, property damage, fire destruction, law enforcement (e.g. roadside breath testing and handling legal challenges in court) and costs to industry, commerce and the voluntary sector. Detailed descriptions of identification, measurement and valuation of these costs were not provided. Out of pocket payments and time investments for behavior changes by participants were accounted for by 11.3% (n ¼ 16) and 20.4% (n ¼ 29) of the studies, respectively. Table 1 shows that effectiveness data were mostly derived from RCTs (n ¼ 80, 56.3%). This included single RCTs (n ¼ 62) and meta-analyses of RCTs (n ¼ 18). Eighteen studies (12.7%) derived effectiveness data from quasi-experiments, which provide an alternative design to the RCT, when randomization is not possible (e.g. in community-based interventions). In some cases it may even be difficult to use an appropriate control group, because people cannot be excluded from participation in the intervention. Two studies evaluating mass media interventions to encourage smoking cessation therefore used historical data as comparator, which were collected among the same population. 49, 50 Other sources of effectiveness data were expert opinion, systematic literature research (not further specified), hypothetical data or combinations of the study designs above.
Costs included
Study designs to determine effectiveness of LBCIs
Discussion
Main finding of this study Economic evaluations of LBCIs identified in this study (n ¼ 142) are characterized by a number of weaknesses. Methods, study design and characteristics of LBCIs are not always Notes: the total number of studies incorporating outcomes at any of the measurement levels is lower than the total number of studies, because two studies did not specify outcome measures. Some studies considered the same outcome on more than one measurement level. Therefore, numbers in columns do not always add up.
reported in sufficient detail to assess relevance and quality of the evidence. Methodological quality showed several areas for improvement and methodological challenges still need to be addressed.
What is already known on this topic
The Wanless reports in the UK pointed out that costeffectiveness evidence to support decision-making about LBCIs is scarce and that applying economic evaluation methods to complex public health interventions, such as LBCIs, is difficult. 51, 52 Influenced by these reports, the National Institute for Health and Care Excellence (NICE) was one of the first organizations worldwide to introduce a systematic and transparent approach to producing guidance for evidence-informed decision-making about public health interventions, including LBCIs. 53 Kelly et al. 6 described methodological challenges emerging during the first years of developing this guidance. Several other researchers also identified methodological challenges 7 -9,12,54,55 and a systematic review by Weatherly et al. 7 showed that few empirical studies tackled these in practice.
What this study adds
This study provides a further exploration of the progress made with addressing methodological challenges in the area of behavior change. It adds to the work of Weatherly et al. Based on our findings several priority areas for improving future evidence were identified.
(i) Essential study details should be better reported.
Quality assessment checklists, such as Drummond et al., 2 Evers et al. 56 and Philips et al. 57 can provide guidance on reporting of methodological aspects of the study. Davidson et al. 58 can be used to identify intervention characteristics essential to report, while Abraham and Michie 59 can assist in describing behavior change techniques.
(ii) To increase compliance with methodological standards, such as performing an incremental analysis, sensitivity analyses and the use of discounting, we suggest that evaluators use good practice guidelines (e.g. Ramsey et al., 15 Caro et al.
60
) when planning and designing new studies. (iii) Long-term costs and outcomes should be incorporated more often. This requires availability of (better) data and more use of mathematical models adopting a lifetime horizon. To improve availability of data for modeling, future research should map out social diffusion effects of LBCIs, as well as relationships between final and intermediate outcomes, in particular for intermediates other than behavior changes and biomedical health indicators. 61, 62 Alternatives to Markov models may be needed to model some of these relationships (e.g. interactions between individuals). 63, 64 More use of long-term modeling may also be encouraged through building modeling skills and reducing costs by using models in multiple applications. 65 (iv) Measures of final outcome need to be developed that allow for incorporation and valuation of broader domains of wellbeing relevant for LBCIs. Such measures are currently not available, but first steps to develop instruments are on their way. For example Lorgelly et al. 66 explored the possibility to develop an outcome measure based on Sen's capability approach. Willingness to pay is an alternative measure for capturing broader domains of wellbeing.
8, 54 One study in this review applied CV to value broader outcomes in willingness to pay, but did not specify which aspects of wellbeing were valued. 16 More experiences with CV are needed to examine feasibility and validity of the method for evaluating LBCIs. (v) Incorporating outcomes for individuals who are not directly targeted is relevant in all behavior change areas examined. Progress was, however, mainly limited to studies evaluating interventions directed at sexual behaviors. These studies can give direction to methods development in other areas (e.g. to consider health impacts of smoking cessation for people exposed to second-hand smoke). 67, 68 (vi) Future research should focus on developing measures of community level change for use within economic evaluation. Hawe, Shiell and Gold 55, 69 propose to build these on system-based approaches to evaluation increasingly used in public health, which describe complex relationships between process and long-term outcomes on multiple levels (e.g. individual, family, institutions, neighborhood and policy level) using logic models and examine intervention impacts by means of a combination of qualitative and quantitative methods. 70, 71 (vii) Reducing health inequities is an important public health objective and therefore relevant to consider in decisionmaking. Future research should test systematic methods to consider equity outcomes both directly within economic evaluation and alongside economic evaluation results. Suggested methods for use within economic evaluation, include for example reviewing background information on equity, presenting cost-effectiveness for equity-relevant subgroups and systematic assessment of expected distributional effects of implementing interventions under evaluation. 11, 72 The equity effectiveness loop framework can help identify equity evidence relevant to consider in decision-making, and the equity methods group of the Cochrane collaboration is a good source for finding such evidence. 73 (viii) It is important that future studies consider relevant nonhealth sector costs. To increase consistency in the costs considered, research should compile an overview of broader costs in each behavior change area and develop guidance on how to identify, measure and value these. (ix) RCTs designs ensure the highest degree of internal validity and are an important source of efficacy evidence. They are however not always feasible or ethical. In these situations natural experiments can be a useful alternative. 74, 75 RCTs also provide limited insights into intervention processes, contextual factors, participant experiences and implementation fidelity. 14, 76 Hence, augmenting RCTs with another study component (e.g. a discrete choice experiment, qualitative study or observational study) may be helpful. 76, 77 Methods to synthesize diverse forms of evidence for decision-making, such as cost-consequence analysis, multi-criteria decision analysis or logic frameworks should be further developed and tested. 14, 78 Finally, to support decision-making using limited evidence, we suggest that evaluators clearly identify costs and outcomes not considered in the study and their expected impact on cost-effectiveness.
Limitations
This review only included full economic evaluations. Hence, it is possible that studies with very low quality (e.g. simple pre-post designs) were excluded and that methodological quality has even been overestimated. Our search strategy was limited to studies included by PubMed and the NHS economic evaluation database before April 2009. Therefore, we cannot preclude the possibility that we have missed relevant studies and that our conclusions do not apply to the most recent years.
Conclusion
Weak evidence on cost-effectiveness currently hampers priority setting between LBCIs. Our study identified a number of steps to improve future evidence, but decisions about allocation of public resources to LBCIs still need to be taken using available evidence. The methods NICE applies to make best use of existing evidence (e.g. adapting existing models from other decision contexts) can provide directions to policy-makers in other countries. 79 
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